CVS Health names Laurie Havanec Chief People Officer

Top of the article

Veteran HR pro will bring a people-first approach to help advance the company's culture

WOONSOCKET, R.I. — CVS Health (NYSE: CVS) today announced that Laurie Havanec will join the company as Executive Vice President and Chief People Officer, effective February 8, 2021. Havanec will succeed Lisa Bisaccia who is retiring after 16 years at the company.

"Laurie is an innovative leader who brings a wealth of experience partnering with executive teams to build strategic, people-focused human resources strategy," said Karen S. Lynch, who will become President and CEO of CVS Health on February 1. "Laurie will lead talent and culture initiatives that support our business strategy, and she will also play a central role in helping to inspire and engage all 300,000 employees across CVS Health."

Havanec joins CVS Health with a distinguished career of over 20 years, most recently serving as Executive Vice President and Chief People Officer of Otis Worldwide Co., the world's leading company for elevator and escalator maintenance, installation and service. She's an experienced HR professional who has worked across all human resources functions including talent development, diversity, equity and inclusion, compensation and benefits, labor and employee relations, and HR systems, shared services and operations.

Before joining Otis, Havanec served as Corporate Vice President of Talent and HR at United Technologies Corporation (UTC) where together with her team, she transformed and modernized the company's talent agenda and priorities. She championed technology and new ways of thinking to create industry-leading practices in engagement, recruitment and performance. Laurie was also a senior HR leader at Aetna.

"It's been said that businesses don't create value; people do. That's why I'm honored to join CVS Health at such a critical time in the company's history. In partnership with our business and HR leadership teams, I look forward to building and maintaining a corporate environment that enables us to achieve our vision to transform health care for consumers across the nation," said Havanec.

Havanec will become a member of the company's executive leadership team and report to Lynch. She has a BS in Marketing and a JD, both from the University of Connecticut.

About CVS Health

CVS Health is a different kind of health care company. We are a diversified health services company with nearly 300,000 employees united around a common purpose of helping people on their path to better health. In an increasingly connected and digital world, we are meeting people wherever they are and changing health care to meet their needs. Built on a foundation of unmatched community presence, our diversified model engages one in three Americans each year. From our innovative new services at HealthHUB locations, to transformative programs that help manage chronic conditions, we are making health care more accessible, more affordable and simply better. Learn more about how we're transforming health at www.cvshealth.com.

Media contact

Ethan Slavin
860-273-6095
SlavinE@Aetna.com

Hide Media Contacts (Sidebar)
No
Press Release
Hide Share
Off
"Likes" Count
1
Display Hero
Off
Topics
CSR Pillars
Audience

CVS Health Corporation announces pricing of tender offers

Top of the article

WOONSOCKET, R.I. — CVS Health Corporation (“CVS Health”, NYSE: CVS) announced today the applicable Reference Yields and Total Consideration (each as summarized in the table below) to be paid in connection with the previously announced cash tender offers (each, a “Tender Offer” and collectively, the “Tender Offers”) for (i) up to $1,500,000,000 aggregate principal amount (the “2023 Notes Maximum Amount”) of its 4.000% Senior Notes due 2023 and 3.700% Senior Notes due 2023 and the 2.800% Senior Notes due 2023 issued by its wholly-owned subsidiary, Aetna Inc. (collectively, the “2023 Notes”) in the priorities set forth in the Offer to Purchase (as defined below) (the “2023 Notes Tender Offers”), (ii) up to $1,049,919,000 aggregate principal amount (the “2025 Notes Maximum Amount”) of its 4.100% Senior Notes due 2025 and 3.875% Senior Notes due 2025 (collectively, the “2025 Notes”) in the priorities set forth in the Offer to Purchase (the “2025 Notes Tender Offers”) and (iii) up to $1,950,081,000 principal amount (the “2028 Notes Maximum Amount” and, together with the 2023 Notes Maximum Amount and the 2025 Notes Maximum Amount, the “Maximum Amounts”) of its 4.300% Senior Notes due 2028 (the “2028 Notes”, and, together with the 2023 Notes and the 2025 Notes, the “Notes”). Each group of Tender Offers that constitutes the 2023 Notes Tender Offers, the 2025 Notes Tender Offers or the 2028 Notes Tender Offer are referred to as the “Capped Tender Offers”. The sum of the 2023 Notes Maximum Amount, the 2025 Notes Maximum Amount and the 2028 Notes Maximum Amount is $4,500,000,000 (the “Aggregate Maximum Amount”), which represents the aggregate principal amount of the Notes subject to the Tender Offers and excludes any Accrued Interest (as defined below) or Early Tender Payment (as defined below). The Tender Offers are being made upon the terms and subject to the conditions set forth in the Offer to Purchase dated December 7, 2020 (as amended or supplemented from time to time, the “Offer to Purchase”), which sets forth a detailed description of the Tender Offers. The Tender Offers are open to all registered holders (individually, a “Holder” and collectively, the “Holders”) of the Notes.

The applicable Reference Yield for the Notes and the Total Consideration for the Notes are summarized in the table below:

Reference Yield for the Notes and the Total Consideration for the Notes

The Total Consideration for each $1,000 principal amount of the Notes was determined in the manner described in the Offer to Purchase by reference to the applicable fixed spread set forth in the table above plus the yield to maturity or first par call date, as the case may be, of the applicable U.S. Treasury reference securities (the “UST Reference Security”) set forth in the table above on the bid-side price of such UST Reference Security as of 9:00 a.m., New York City time, on December 21, 2020.

The Notes validly tendered and not validly withdrawn at or prior to 5:00 p.m., New York City time, on December 18, 2020 (the “Early Tender Date”) will be eligible to receive the applicable Total Consideration, which includes the Early Tender Payment of $30 per $1,000 principal amount of Notes.

CVS Health expects to accept for purchase and make payment for Notes validly tendered and not validly withdrawn at or prior to the Early Tender Date on December 22, 2020 (the “Early Settlement Date”).

Holders of all Notes validly tendered and not validly withdrawn at or prior to the Early Tender Date and accepted for purchase are eligible to receive the applicable Total Consideration, which includes the applicable Early Tender Payment of $30 per $1,000 principal amount of Notes tendered at or prior to the Early Tender Date (the “Early Tender Payment”). In addition to the applicable Total Consideration, Holders of Notes accepted for purchase will receive accrued and unpaid interest up to, but not including, the Early Settlement Date (“Accrued Interest”).

Because the aggregate principal amount of 2023 Notes validly tendered would exceed the 2023 Notes Maximum Amount, CVS Health expects that it will accept validly tendered 3.700% Senior Notes due 2023 on a prorated basis in accordance with the Offer to Purchase and none of the validly tendered 2.800% Senior Notes due 2023. Because the aggregate principal amount of 2025 Notes validly tendered would exceed the 2025 Notes Maximum Amount, CVS Health expects that it will accept all of the validly tendered 4.100% Senior Notes due 2025 and none of the 3.875% Senior Notes due 2025. Because the principal amount of 2028 Notes validly tendered would exceed the 2028 Notes Maximum Amount, CVS Health expects that it will accept validly tendered 4.300% Senior Notes due 2028 on a prorated basis in accordance with the Offer to Purchase.

Because CVS Health expects to accept for purchase the Maximum Aggregate Amount of Notes, no additional Notes will be purchased pursuant to the Tender Offers after the Early Settlement Date. In connection with the recent announcement by the U.S. government that executive departments and agencies of the federal government will be closed on December 24, 2020, the expiration date (the “Expiration Date”) will be changed from 11:59 p.m., New York City time, January 5, 2021 to 11:59 p.m., New York City time, January 6, 2021. As described in the Offer to Purchase, Notes tendered and not accepted for purchase will be promptly returned to the tendering Holder’s account.

CVS Health expressly reserves the right, in its sole discretion, subject to applicable law, to terminate the Tender Offers at any time prior to the Expiration Date. The Tender Offers are not conditioned on any minimum principal amount of Notes being tendered but the Tender Offers are subject to certain conditions as described in the Offer to Purchase. Each Tender Offer is a separate offer. None of the Capped Tender Offers are conditioned on each other. Each Tender Offer may be individually amended, extended or terminated by CVS Health.

CVS Health has retained Barclays Capital Inc., BofA Securities, Inc. and Goldman Sachs & Co. LLC to act as Dealer Managers for the Tender Offers. D.F. King & Co., Inc. has been retained to act as the Tender and Information Agent for the Tender Offers. Requests for assistance relating to the procedures for tendering Notes may be directed to the Tender and Information Agent either by email at cvs@dfking.com, or by phone (212) 269-5550 (for banks and brokers only) or (800) 714-3305 (for all others toll free). Requests for assistance relating to the terms and conditions of the Tender Offers may be directed to Barclays Capital Inc. at (800) 438-3242 (toll free) or (212) 528-7581 (collect), BofA Securities, Inc. at (980) 387-3907 (collect) or Goldman Sachs & Co. LLC at (212) 902-6351 (collect). Beneficial owners may also contact their broker, dealer, commercial bank, trust company or other nominee for assistance.

This press release does not constitute an offer to sell or purchase, or a solicitation of an offer to sell or purchase, or the solicitation of tenders with respect to, the Notes. No offer, solicitation, purchase or sale will be made in any jurisdiction in which such an offer, solicitation, or sale would be unlawful. The Tender Offers are being made solely pursuant to the Offer to Purchase made available to Holders of the Notes. None of CVS Health, the Dealer Managers, Tender and Information Agent or the trustees with respect to the Notes, or any of their respective affiliates, is making any recommendation as to whether or not Holders should tender or refrain from tendering all or any portion of their Notes in response to the Tender Offers. Holders are urged to evaluate carefully all information in the Offer to Purchase, consult their own investment and tax advisers and make their own decisions whether to tender Notes in the Tender Offers, and, if so, the principal amount of Notes to tender.

Investor contact

Valerie Haertel
Senior Vice President
Investor Relations
(401) 770-4050

Media contact

T.J. Crawford
Vice President
External Affairs
(212) 457-0583

About CVS Health

CVS Health is a different kind of health care company. We are a diversified health services company with nearly 300,000 employees united around a common purpose of helping people on their path to better health. In an increasingly connected and digital world, we are meeting people wherever they are and changing health care to meet their needs. Built on a foundation of unmatched community presence, our diversified model engages one in three Americans each year. From our innovative new services at HealthHUB® locations, to transformative programs that help manage chronic conditions, we are making health care more accessible, more affordable… and simply better. Learn more about how we're transforming health at www.cvshealth.com.

Cautionary Statement Concerning Forward-Looking Statements

The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by or on behalf of CVS Health Corporation. By their nature, all forward-looking statements are not guarantees of future performance or results and are subject to risks and uncertainties that are difficult to predict and/or quantify. Actual results may differ materially from those contemplated by the forward-looking statements due to the risks and uncertainties related to the COVID-19 pandemic, the geographies impacted and the severity and duration of the pandemic, the pandemic's impact on the U.S. and global economies and consumer behavior and health care utilization patterns, and the timing, scope and impact of stimulus legislation and other federal, state and local governmental responses to the pandemic, as well as the risks and uncertainties described in our Securities and Exchange Commission filings, including those set forth in the Risk Factors section and under the heading "Cautionary Statement Concerning Forward-Looking Statements" in our most recently filed Annual Report on Form 10-K, our Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2020 and our recently filed Current Reports on Form 8-K.

You are cautioned not to place undue reliance on CVS Health's forward looking statements. CVS Health's forward-looking statements are and will be based upon management's then-current views and assumptions regarding future events and operating performance, and are applicable only as of the dates of such statements. CVS Health does not assume any duty to update or revise forward-looking statements, whether as a result of new information, future events, uncertainties or otherwise.

Hide Media Contacts (Sidebar)
No
Press Release
Hide Share
Off
"Likes" Count
0
Display Hero
Off
CSR Pillars
Audience

IlliniCare Health rebrands to Aetna Better Health of Illinois

Top of the article

CHICAGO — Aetna Better Health, a CVS Health company, today announced IlliniCare Health, a Medicaid managed care plan that serves members across Illinois, has officially rebranded and changed its name to Aetna Better Health of Illinois (ABH-IL). Materials for plan year 2021 will reflect the new Aetna Better Health of Illinois name.

Aetna Better Health of Illinois offers quality, affordable health care to individuals through the state’s HealthChoice Illinois Medicaid program. The National Committee for Quality Assurance (NCQA) recently awarded Aetna Better Health of Illinois accreditation status and the health plan’s Long-Term Services and Supports (LTSS) program received LTSS distinction with a nearly perfect score.

"As part of the Aetna Better Health family of health plans, we will continue providing our members with access to quality care and supporting them on their path to better health," said Kim Foltz, CEO, Aetna Better Health of Illinois. "We also remain dedicated to working with the State of Illinois, our providers and community-based organizations to deliver efficient, effective, person-centered care that drives improvements in service delivery, member experience and quality outcomes."

During the brand transition, there will be no changes to member coverage or to their points of contact. Members began receiving rebranded plan materials with the Aetna logo, including new member identification cards, in late November.

Aetna Better Health of Illinois employs over 900 associates, with most located in the state, and serves nearly 400,000 members in 102 counties.

About Aetna Medicaid

Aetna Medicaid Administrators LLC (Aetna Medicaid), a CVS Health business, has over 30 years of experience managing the care of the most medically vulnerable, using innovative approaches and a local presence in each market to achieve both successful health care results and effective cost outcomes. Aetna Medicaid has particular expertise serving high-need Medicaid members, including those who are dually eligible for Medicaid and Medicare. Currently, Aetna Medicaid owns and/or administers Medicaid managed health care plans under the names of Aetna Better Health and other affiliate names. Together, these plans serve approximately 2.6 million people in 16 states, including Arizona, California, Florida, Illinois, Kansas, Kentucky, Louisiana, Maryland, Michigan, New Jersey, New York, Ohio, Pennsylvania, Virginia, West Virginia, and Texas. For more information, see www.aetnabetterhealth.com.

A family of four lying in a circle on the floor wearing masks looking up at the camera
Hide Media Contacts (Sidebar)
No
Press Release
Hide Share
Off
"Likes" Count
2
Display Hero
On
Campaign
CSR Pillars
Locations
Audience

CVS Health Corporation announces early results and upsize of previously announced cash tender offers to an aggregate principal amount of $4,500,000,000 from $4,000,000,000 of certain outstanding notes

Top of the article

WOONSOCKET, R.I. — CVS Health Corporation ("CVS Health", NYSE: CVS) announced today the early results of the previously announced cash tender offers (each, a "Tender Offer" and collectively, the "Tender Offers") and that it is amending the Tender Offers by increasing the Aggregate Maximum Amount (as defined below) of the Tender Offers to $4,500,000,000 from $4,000,000,000 and by increasing the 2025 Notes Maximum Amount (as defined below) to $1,049,919,000 from $1,000,000,000 and the 2028 Notes Maximum Amount (as defined below) to $1,950,081,000 from $1,500,000,000. The Tender Offers, as amended, consist of (i) up to $1,500,000,000 aggregate principal amount (the "2023 Notes Maximum Amount") of its 4.000% Senior Notes due 2023 and 3.700% Senior Notes due 2023 and the 2.800% Senior Notes due 2023 issued by its wholly-owned subsidiary, Aetna Inc. (collectively, the "2023 Notes") in the priorities set forth in the table below (the "2023 Notes Tender Offers"), (ii) up to $1,049,919,000 aggregate principal amount (as increased and amended, the "2025 Notes Maximum Amount") of its 4.100% Senior Notes due 2025 and 3.875% Senior Notes due 2025 (collectively, the "2025 Notes") in the priorities set forth in the table below (the "2025 Notes Tender Offers") and (iii) up to $1,950,081,000 principal amount (as increased and amended, the "2028 Notes Maximum Amount" and, together with the 2023 Notes Maximum Amount and the 2025 Notes Maximum Amount, the "Maximum Amounts") of its 4.300% Senior Notes due 2028 (the "2028 Notes", and, together with the 2023 Notes and the 2025 Notes, the "Notes"). Each group of Tender Offers that constitutes the 2023 Notes Tender Offers, the 2025 Notes Tender Offers or the 2028 Notes Tender Offer are referred to as the "Capped Tender Offers". The sum of the increased 2023 Notes Maximum Amount, the 2025 Notes Maximum Amount and the 2028 Notes Maximum Amount is $4,500,000,000 (as increased and amended, the "Aggregate Maximum Amount"), which represents the aggregate principal amount of the Notes subject to the Tender Offers and excludes any Accrued Interest (as defined below) or Early Tender Payment (as defined below). The Tender Offers are being made upon the terms and subject to the conditions set forth in the Offer to Purchase dated December 7, 2020 (as amended or supplemented from time to time, the "Offer to Purchase"), which sets forth a detailed description of the Tender Offers. The Tender Offers are open to all registered holders (individually, a "Holder" and collectively, the "Holders") of the Notes.

The applicable Reference Yield for the Notes and the Total Consideration for the Notes are summarized in the table below:

The consideration to be paid in the Tender Offers for each series of Notes validly tendered and expected to be accepted for purchase as described in the Offer to Purchase (the "Total Consideration") will be determined at 9:00 a.m., New York City time, on December 21, 2020.

As of 5:00 p.m., New York City time, on December 18, 2020 (the "Early Tender Date"), as reported by D.F. King & Co., Inc., the Tender and Information Agent for the Tender Offers, the principal amounts of the Notes listed in the table above have been validly tendered and not validly withdrawn. The Withdrawal Deadline of 5:00 p.m., New York City time, on December 18, 2020 has passed and, accordingly, Notes validly tendered in the Tender Offers may no longer be withdrawn.

CVS Health expects to accept for purchase and make payment for Notes validly tendered and not validly withdrawn at or prior to the Early Tender Date on December 22, 2020 (the "Early Settlement Date"), subject to the acceptance priority levels applicable to the relevant series as described in the Offer to Purchase and, in the case of the 3.700% Senior Notes due 2023 for the 2023 Notes Tender Offers and in the case of the 4.300% Senior Notes due 2028 for the 2028 Notes Tender Offer to proration as described below.

Because the aggregate principal amount of 2023 Notes validly tendered would exceed the 2023 Notes Maximum Amount, CVS Health expects that it will accept validly tendered 3.700% Senior Notes due 2023 on a prorated basis in accordance with the Offer to Purchase and none of the validly tendered 2.800% Senior Notes due 2023. Because the aggregate principal amount of 2025 Notes validly tendered would exceed the 2025 Notes Maximum Amount, CVS Health expects that it will accept all of the validly tendered 4.100% Senior Notes due 2025 and none of the 3.875% Senior Notes due 2025. Because the principal amount of 2028 Notes validly tendered would exceed the 2028 Notes Maximum Amount, CVS Health expects that it will accept validly tendered 4.300% Senior Notes due 2028 on a prorated basis in accordance with the Offer to Purchase.

Because CVS Health expects to accept for purchase the Maximum Aggregate Amount of Notes, no additional Notes will be purchased pursuant to the Tender Offers after the Early Settlement Date. In connection with the recent announcement by the U.S. government that executive departments and agencies of the federal government will be closed on December 24, 2020, the expiration date (the "Expiration Date") will be changed from 11:59 p.m., New York City time, January 5, 2021 to 11:59 p.m., New York City time, January 6, 2021. As described in the Offer to Purchase, Notes tendered and not accepted for purchase will be promptly returned to the tendering Holder's account.

Holders of all Notes validly tendered and not validly withdrawn at or prior to the Early Tender Date and accepted for purchase are eligible to receive the applicable Total Consideration, which includes the applicable Early Tender Payment of $30 per $1,000 principal amount of Notes tendered at or prior to the Early Tender Date (the "Early Tender Payment"). In addition to the applicable Total Consideration, Holders of Notes accepted for purchase will receive accrued and unpaid interest up to, but not including, the Early Settlement Date ("Accrued Interest").

CVS Health expressly reserves the right, in its sole discretion, subject to applicable law, to terminate the Tender Offers at any time prior to the Expiration Date. The Tender Offers are not conditioned on any minimum principal amount of Notes being tendered but the Tender Offers are subject to certain conditions as described in the Offer to Purchase. Each Tender Offer is a separate offer. None of the Capped Tender Offers are conditioned on each other. Each Tender Offer may be individually amended, extended or terminated by CVS Health.

CVS Health has retained Barclays Capital Inc., BofA Securities, Inc. and Goldman Sachs & Co. LLC to act as Dealer Managers for the Tender Offers. D.F. King & Co., Inc. has been retained to act as the Tender and Information Agent for the Tender Offers. Requests for assistance relating to the procedures for tendering Notes may be directed to the Tender and Information Agent either by email at cvs@dfking.com, or by phone (212) 269-5550 (for banks and brokers only) or (800) 714-3305 (for all others toll free). Requests for assistance relating to the terms and conditions of the Tender Offers may be directed to Barclays Capital Inc. at (800) 438-3242 (toll free) or (212) 528-7581 (collect), BofA Securities, Inc. at (980) 387-3907 (collect) or Goldman Sachs & Co. LLC at (212) 902-6351 (collect). Beneficial owners may also contact their broker, dealer, commercial bank, trust company or other nominee for assistance.

This press release does not constitute an offer to sell or purchase, or a solicitation of an offer to sell or purchase, or the solicitation of tenders with respect to, the Notes. No offer, solicitation, purchase or sale will be made in any jurisdiction in which such an offer, solicitation, or sale would be unlawful. The Tender Offers are being made solely pursuant to the Offer to Purchase made available to Holders of the Notes. None of CVS Health, the Dealer Managers, Tender and Information Agent or the trustees with respect to the Notes, or any of their respective affiliates, is making any recommendation as to whether or not Holders should tender or refrain from tendering all or any portion of their Notes in response to the Tender Offers. Holders are urged to evaluate carefully all information in the Offer to Purchase, consult their own investment and tax advisers and make their own decisions whether to tender Notes in the Tender Offers, and, if so, the principal amount of Notes to tender.

About CVS Health

CVS Health is a different kind of health care company. We are a diversified health services company with nearly 300,000 employees united around a common purpose of helping people on their path to better health. In an increasingly connected and digital world, we are meeting people wherever they are and changing health care to meet their needs. Built on a foundation of unmatched community presence, our diversified model engages one in three Americans each year. From our innovative new services at HealthHUB locations, to transformative programs that help manage chronic conditions, we are making health care more accessible, more affordable and simply better. Learn more about how we're transforming health at www.cvshealth.com.

Cautionary Statement Concerning Forward-Looking Statements

The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by or on behalf of CVS Health Corporation. By their nature, all forward-looking statements are not guarantees of future performance or results and are subject to risks and uncertainties that are difficult to predict and/or quantify. Actual results may differ materially from those contemplated by the forward-looking statements due to the risks and uncertainties related to the COVID-19 pandemic, the geographies impacted and the severity and duration of the pandemic, the pandemic's impact on the U.S. and global economies and consumer behavior and health care utilization patterns, and the timing, scope and impact of stimulus legislation and other federal, state and local governmental responses to the pandemic, as well as the risks and uncertainties described in our Securities and Exchange Commission filings, including those set forth in the Risk Factors section and under the heading "Cautionary Statement Concerning Forward-Looking Statements" in our most recently filed Annual Report on Form 10-K, our Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2020 and our recently filed Current Reports on Form 8-K.

You are cautioned not to place undue reliance on CVS Health's forward looking statements. CVS Health's forward-looking statements are and will be based upon management's then-current views and assumptions regarding future events and operating performance, and are applicable only as of the dates of such statements. CVS Health does not assume any duty to update or revise forward-looking statements, whether as a result of new information, future events, uncertainties or otherwise.

Hide Media Contacts (Sidebar)
No
Press Release
Hide Share
Off
"Likes" Count
1
Display Hero
Off
CSR Pillars
Audience

Celebrating our impact

Celebrating our impact
Bottom of the article

As we reflect on 2020, we’re incredibly grateful for the contributions of our nearly 300,000 colleagues.

Whether they were in our stores, virtual offices or in the community, our colleagues rose to the challenge to support our customers and members when they needed us most.

A CVS Health employee, wearing a face mask, smiles and assists a member with COVID-19 testing.
Hide Media Contacts (Sidebar)
No
Article
Hide Share
Off
"Likes" Count
23
Display Hero
Off
Assets
Programs
CSR Pillars
Audience
Neela Montgomery

Neela Montgomery

Executive Vice President, CVS Health and President, CVS Pharmacy

Neela Montgomery is Executive Vice President, CVS Health and President, CVS Pharmacy, with oversight of the company’s 10,000 pharmacies across the United States.

Prior to coming to CVS Health, Neela was CEO of Crate & Barrel Holdings, a global home furnishings retailer that includes Crate & Barrel, CB2 and Hudson Grace. She oversaw all aspects of the company and led a progressive growth strategy by developing tools, culture and relationships with retailers, manufacturers and tech to propel the heritage brand into the future of retail. By the end of her tenure, the business was realizing 50% of its sales from ecommerce.
 
Before 2017, she was on the executive board of Otto Group, responsible for retail and brands and Executive Chairwoman across five operating companies, including Crate & Barrel. Earlier in her career she spent 12 years at Tesco PLC in various leadership roles in strategy, international, merchandising, eCommerce and grocery retail. During her time at Tesco, she rose to oversee the General Merchandise division for the UK business and sat on the UK Board of Directors. 

Neela studied English Literature at Oxford University and holds an MBA from INSEAD in France and Singapore. She is a member of the 2020 Class of Henry Crown Fellows within the Aspen Institute, which challenges entrepreneurial leaders to build a better society. 
Since 2017 she has been a member of the Board of Directors of Logitech and serves on its Audit committee. 

CVS Health completes rollout of time delay safes in all of its Oklahoma pharmacies

Top of the article

New Safes for controlled substances anticipated to help reduce robbery incidents

All 79 CVS Pharmacy locations in the state now using time-delay safe technology

WOONSOCKET, R.I. — As part of an ongoing commitment to helping build healthier and safer communities, CVS Health (NYSE: CVS) completed the installation of time delay safe technology in all of its 79 Oklahoma CVS Pharmacy locations, including those in Target stores. The safes are anticipated to help prevent pharmacy robberies and the potential for associated diversion of controlled substance medications including opioid medications such as oxycodone and hydrocodone by electronically delaying the time it takes for pharmacy employees to open the safe. In addition, the safes are anticipated to help CVS Pharmacy ensure the safety and well-being of its customers and employees.

"I commend the leadership of CVS Pharmacy for implementing this technology that will act as a deterrent for would-be pharmacy thieves and will also thwart diversion from stores," said Oklahoma Attorney General Mike Hunter. "The opioid epidemic has ravaged communities across our state and nation. With the ongoing Coronavirus pandemic, experts have seen a resurgence of opioid addictions. This technology will ensure the safety of those behind the counter and from these dangerous drugs getting into the wrong hands. Innovation and ingenuity are just as important as policy proposals when protecting our communities. I thank the company for its work in keeping Oklahomans safe."

CVS Health first implemented time delay safe technology in 2015 in CVS Pharmacy locations across Indianapolis, a city experiencing a high volume of pharmacy robberies at the time. The company saw a 70 percent decline in pharmacy robberies among the Indianapolis stores where time delay safes had been installed.

Since then, the company has introduced time delay safes across 15 states and the District of Columbia, resulting in a 50 percent decline in robberies at CVS pharmacies in those local communities.

"Pharmacy robberies are a challenging issue for every pharmacy, and we are committed to doing all we can to reduce the number of incidents in our Oklahoma stores," said Tom Moriarty, Chief Policy Officer and General Counsel, CVS Health. "We have seen that time delay safes, combined with other security policies and procedures in place at our stores, can greatly reduce these incidents and are pleased to roll out this enhanced security measure. These safes will help ensure that our pharmacies remain a safe environment for our patients and colleagues."

The time delay function cannot be overridden and is designed to serve as a deterrent to would-be pharmacy robbers whose goal is to enter and exit their robbery targets as quickly as possible. All CVS Pharmacy locations in Oklahoma with time delay safes display visible signage warning that time delay safes are in use to prevent on-demand access to controlled substance narcotics.

CVS Health's time delay safe program is one of many company initiatives to help address and prevent prescription opioid misuse and diversion.

Through its Safe Medication Disposal Program in Oklahoma, for example, the company has installed 23 drug disposal kiosks in select CVS Pharmacy locations in the state.

Presently, the company supports more than 2,800 safe medication disposal units in CVS Pharmacy locations nationwide. Over the past several years, the company has also donated over 1,000 units to local law enforcement. Together, these existing medication disposal units have collected more than 2.1 million pounds of unwanted medications that might otherwise have been diverted, misused or ended up in the water supply.

Located in the pharmacy area of the CVS store and similar in design to a postal box, the safe medication disposal units allow customers to drop off unused prescriptions in a container or in sealed plastic bags if liquids or multiple medications are included.

Additionally, CVS Pharmacy locations that do not offer a safe medication disposal kiosk offer DisposeRx packets at no cost to patients filling an opioid prescription for the first time. According to the manufacturer, when warm water and the DisposeRx powder are added to a container, the combination breaks down medications including powders, pills, capsules, tablets, liquids or patches to a non-divertible biodegradable gel, allowing for safe disposal in the trash at home.

CVS Health's commitment to helping prevent and address drug misuse and diversion also extends to community education and increasing access to the opioid overdose-reversal drug naloxone.

Our Pharmacists Teach Program connects volunteer CVS pharmacists with local students to encourage conversation and teach youth about the dangers of prescription drug misuse. Since 2015, our pharmacists have volunteered their time and delivered curriculum to nearly 600,000 teens and parents across the country. We've partnered with Discovery Education to expand the reach of Pharmacists Teach into more classrooms with a no-cost digital prevention program called Dose of Knowledge. This program provides standards-aligned resources to educators and pharmacists across the U.S. and strives to empower educators and pharmacists to address substance misuse and educate students to make good decisions for the health and well-being of themselves and their community.

Finally, CVS Pharmacy patients can now access the opioid overdose-reversal drug naloxone without an individual prescription at every CVS Pharmacy location nationwide, including all 50 states, Washington, D.C. and Puerto Rico. CVS Health has also worked with Google to help people locate naloxone at CVS Pharmacy and other locations in their community using Google's locator tool.

With its national reach and local presence, CVS Health has been working hard to help address opioid misuse and diversion with an enterprise-wide approach. To learn more about CVS Health's efforts, visit the company's Opioid Response website.

For downloadable time delay safe photos, please visit the Media Resource Center.

About CVS Health

CVS Health is a different kind of health care company. We are a diversified health services company with nearly 300,000 employees united around a common purpose of helping people on their path to better health. In an increasingly connected and digital world, we are meeting people wherever they are and changing health care to meet their needs. Built on a foundation of unmatched community presence, our diversified model engages one in three Americans each year. From our innovative new services at HealthHUB locations, to transformative programs that help manage chronic conditions, we are making health care more accessible, more affordable and simply better. Learn more about how we're transforming health at www.cvshealth.com.

Media contact

Monica Prinzing
831-241-8294
PrinzingM@aetna.com

Interior of a CVS Pharmacy store near the checkout area
Hide Media Contacts (Sidebar)
No
Press Release
Hide Share
Off
"Likes" Count
1
Display Hero
On
Locations
Audience

Longs Drugs debuts HealthHUB experience to serve Hawaii

Top of the article

Three HealthHUB locations will help make chronic disease management and overall health and wellness more simple, convenient and affordable

As COVID-19 continues to impact the state, new HealthHUBs broaden access to care in person and virtually

HONOLULU — Longs Drugs and its parent company CVS Health (NYSE: CVS) today held a community grand opening ceremony and blessing to debut HealthHUB, a new store format at three store locations in Hawaii. The innovative health care experience enables individuals and families to access health care that is more accessible, affordable and simply better.

Following the ceremony, which included traditional Hawaiian and Chinese blessings, CVS Health committed to a second year of funding to Aloha United Way in support of Hawaii's efforts to meet the health needs of Oahu's homeless population. The $25,000 grant will bolster Hawaii Homeless Healthcare Hui's (H4) plans to build a permanent, comprehensive service facility in Iwilei to better provide its medical services.

The new HealthHUB locations will continue to offer products specifically procured for the people of Hawaii, and feature a broader range of connected health care services to help patients better manage chronic conditions; more products and services focused on overall health and wellness; and trusted advice and personalized care that can be accessed virtually and with the ease of walking into the following Longs Drugs:

  • Longs Drugs, 45 480 Kaneohe Bay Drive, Kaneohe, HI 96744

  • Longs Drugs, 98-1005 Moanalua Road, Aiea, HI 96701

  • Longs Drugs, 925 California Avenue, Wahiawa, HI 96786

"We're delivering real change to the health care system, and that is the focus of our new HealthHUB locations across the state," said Scott Sutton, Region Director for Longs Drugs in Hawaii. "Customers tell us they want local access to convenient, personalized and integrated health care. Our HealthHUBs do just that elevating the store and our digital touchpoints into a seamless, community-based health care offering that complements the patient-doctor relationship and provides consumers with accessible and knowledgeable experts they trust, in order to coordinate a better health care experience at a lower cost."

CVS Health began piloting HealthHUBs in 2018 to overwhelming customer satisfaction. The introduction of HealthHUB in Hawaii is part of the company's strategy to scale the program nationally and comes at a critical time when the country is addressing a global pandemic.

"As COVID-19 continues to impact Hawaii and communities across the country, many Americans have delayed visiting a doctor for routine care, a decision that can have serious, long-term consequences," continued Sutton. "The addition of HealthHUBs across the state means the community now has convenient locations for health and wellness checks, immunizations, treatment of minor illnesses and injuries, screening for chronic conditions, and much more."

For many Americans, health care can be difficult to navigate. During the COVID-19 pandemic, and at a time when chronic disease continues to grow in prevalence and impact in the U.S., patients are facing complexities and fragmentation when seeking the right care. Today, one in two Americans has at least one chronic illness, with data showing that close to $500 billion of the costs associated with chronic disease are avoidable.http://www.fightchronicdisease.org/sites/default/files/TL221_final.pdf  What's more, nine out of 10 (91%) patients say they need more help with chronic disease management.https://cvshealth.com/sites/default/files/cvs-health-improving-chronic-disease-care-and-outcomes.pdf

CVS Health created HealthHUBs to help people manage chronic conditions more conveniently and affordably by improving the overall patient experience and featuring a wide array of accessible health and wellness products, clinical services and expertise.

The HealthHUB locations inside Longs Drugs feature an on-site Care Concierge team focused on customer engagement, including educating customers about new service offerings, helping them navigate in-store services, and connecting them to a team of health care providers. Among the key features incorporated in a HealthHUB include:

Greater selection of health and wellness products

  • Shop hundreds of products such as health devices that sync to your mobile phone, aromatherapy, fitness essentials, durable medical equipment, sleep apnea products and more.

  • Learning table for customers to explore health and wellness apps and shop our expanded assortment of products on CVS.com.

More personalized support at the pharmacy

  • Education and counseling for patients with chronic conditions, helping to create personalized plans that enable better health outcomes and reduces medical costs.

  • Pharmacist-led diabetes counseling and smart device coaching for select blood glucose monitors.

  • Smoking cessation plans for patients and caregivers to help patients quit smoking.

Expanded services at MinuteClinic

  • Continued convenient access to services for minor illnesses and injuries, as well as immunizations, wellness and health checks.

  • Screening, treatment and monitoring for chronic conditions such as high blood pressure, high cholesterol and diabetes.

  • End-to-end sleep apnea solution, including sleep assessment by an independent third-party provider.

  • Suite of services to help manage common health conditions for young adults.

  • Phlebotomy services in conjunction with a MinuteClinic visit.

"We are pleased that Longs Drugs at Windward City Shopping Center now offers the vital and convenient services of the new HealthHUB," said Sarah A. Mandeville (S), Property Manager of Windward City Shopping Center. "The investment made to bring this innovative resource to our Windward Oahu location demonstrates the continued commitment of Longs Drugs and CVS Health to this special community."

CVS Health operates 500 HealthHUB locations in 29 states, with plans to have 600 operational by the end of the year. The company is on track to bring its HealthHUB experience to 1500 stores by the end of 2021.

Visit our website to learn more about products and services available through our HealthHUB locations. For downloadable photos and videos available for media use, visit our HealthHUB Media Gallery.

About CVS Health

CVS Health is a different kind of health care company. We are a diversified health services company with nearly 300,000 employees united around a common purpose of helping people on their path to better health. In an increasingly connected and digital world, we are meeting people wherever they are and changing health care to meet their needs. Built on a foundation of unmatched community presence, our diversified model engages one in three Americans each year. From our innovative new services at HealthHUB locations, to transformative programs that help manage chronic conditions, we are making health care more accessible, more affordable and simply better. Learn more about how we're transforming health at www.cvshealth.com.

Media contact

Joe Goode
401-378-5220
Joseph.Goode@CVSHealth.com

A CVS pharmacists, seen standing in front of the Pharmacy counter and HealthHUB, wearing personal protective equipment (PPE).
Hide Media Contacts (Sidebar)
No
Press Release
Hide Share
Off
"Likes" Count
2
Display Hero
On
Campaign
Locations
Audience

CVS Health to present at the Evercore ISI 3rd annual HealthCONx 2020

Top of the article

WOONSOCKET, R.I. — CVS Health Corporation (NYSE: CVS) today announced that Larry Merlo, President and Chief Executive Officer; and Eva Boratto, Executive Vice President and Chief Financial Officer; and Karen Lynch, Executive Vice President and President of Aetna will be participating in a fireside chat with investors at the Evercore ISI 3rd Annual Global HealthCONx Conference on December 3, 2020, at approximately 12:10 PM ET.

About CVS Health

CVS Health employees are united around a common goal of becoming the most consumer-centric health company in the world. We're evolving based on changing consumer needs and meeting people where they are, whether that's in the community at one of our nearly 10,000 local touchpoints, in the home, or in the palm of their hand. Our newest offerings - from HealthHUB locations that are redefining what a pharmacy can be, to innovative programs that help manage chronic conditions are designed to create a higher-quality, simpler and more affordable experience. Learn more about how we're transforming health at http://www.cvshealth.com.

Hide Media Contacts (Sidebar)
No
Press Release
Hide Share
Off
"Likes" Count
2
Display Hero
Off
CSR Pillars
Audience

Inclusivity & sustainability

We are committed to driving inclusive and sustainable business in support of the communities we serve.

A smiling doctor in a lab coat and red shirt stands in front of a building with her arms crossed.
A mother and her son sit on their couch and share a tender moment.
A woman in a wheel chair laughs.
A teenager wears gloves to pick up plastic waste in a park.